Metraipolis › archive › dc_b5653302aa07

A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable… — Europe PMC PMID:30362335

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/30362335
DOI: 10.22034/apjcp.2018.19.10.2973
License (as archived): solo-consultazione
Archived: 2026-11-04T23:16:25.741Z
SHA-256 of the archived text: 627fdaf2e1bea67e16b282c1ca10dab3ae147c50fbfa80604e06da1a5ba726b0
Stable URL of this page: https://metraipolis.com/documento/dc_b5653302aa07

How to cite

A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable… — Europe PMC PMID:30362335 — Europe PMC (en), https://europepmc.org/article/MED/30362335 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5653302aa07 (Metraipolis archive dc_b5653302aa07, sha256 627fdaf2e1bea67e16b282c1ca10dab3ae147c50fbfa80604e06da1a5ba726b0)

BibTeX

@misc{dcb5653302aa07,
  title = {A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable… — Europe PMC PMID:30362335},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/30362335},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5653302aa07; sha256 627fdaf2e1bea67e16b282c1ca10dab3ae147c50fbfa80604e06da1a5ba726b0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/30362335. Agents can read the archived copy with the MCP tool read_document.